Skip to content

Is amitriptyline effective in the management of chronic low back pain?

Is low dose amitriptyline more effective than an active placebo in the management of chronic low back pain? A double-blind, randomized, placebo-controlled trial.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000131853
Enrollment
146
Registered
2012-01-30
Start date
2012-04-30
Completion date
2015-11-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Chronic low back pain is a major public health problem. Antidepressants are one commonly prescribed treatment for low back pain, and are used not only to treat depression and insomnia, but chronic pain. Their use is rapidly increasing, despite lack of supportive evidence and conflicting recommendations from clinical guidelines. Aims: In community-based adults with chronic low back pain, we aim to determine: 1. If low dose amitriptyline (tricyclic antidepressant) is more effective than an active placebo in the management of pain 2. If low dose amitriptyline is more effective than an active placebo in improving disability and reducing work absence and hindrance. Methods: A double-blind, randomized, placebo-controlled trial will be conducted. We will recruit 150 subjects with chronic low back pain. Participants will receive low-dose amitriptyline or an active placebo for 6 months. Pain, disability and work absence and hindrance will be assessed at baseline, 3 and 6 months using valid measures. Implications: If antidepressants are found to be effective, it will provide high quality evidence for their use, potentially enabling this treatment option to be considered by more individuals with chronic low back pain. If we do not find antidepressants to be effective, then this trial will provide strong evidence to review international guidelines that recommend their use and to evaluate the extensive use of tricyclic antidepressants for chronic low back pain.

Interventions

Low-dose amitriptyline; 25mg per day; capsule/oral administration; 6 month duration

Sponsors

Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18-75 years 2. Chronic low back pain (Chronic > 3 months in duration; pain in the region bordered above by the costal margin and below by the gluteal folds)

Exclusion criteria

- Specific pathological entities, such as infection, metastasis, osteoporosis, fractures. - Major co-existing illness which might confound assessment of function or for which amitriptyline may be inappropriate - Another significant musculoskeletal conditions - History of psychosis - Patients with any diagnosed depression with or without the use of medication - Any prior or current use of antidepressants - Current use of opioids - Any contra-indication or allergy to amitriptyline - Pregnancy or planning/trying to become pregnant or breastfeeding - Inability to provide informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 12, 2026